Piperazine derivatives and their use as 5-HT1A antagonists
A compound of general formula (A) is described together with pharmaceutically acceptable acid addition salts thereof. The compound is a 5-HT1A antagonist which is useful in the treatment of CNS disorders in mammals.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
19.08.1998
|
| Edition | 6 |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | A compound of general formula (A) is described together with pharmaceutically acceptable acid addition salts thereof. The compound is a 5-HT1A antagonist which is useful in the treatment of CNS disorders in mammals. |
|---|---|
| AbstractList | A compound of general formula (A) is described together with pharmaceutically acceptable acid addition salts thereof. The compound is a 5-HT1A antagonist which is useful in the treatment of CNS disorders in mammals. |
| Author | A. FENSOME M. G. KELLY H. L. MANSELL |
| Author_xml | – fullname: A. FENSOME – fullname: M. G. KELLY – fullname: H. L. MANSELL |
| BookMark | eNrjYmDJy89L5WSwCsgsSC1KrMrMS1VISS3KLEssySxLLVZIzEtRKMlIzSxSKC1OVUgsVjDV9QgxdASKlySm5-dlFpcU8zCwpiXmFKfyQmluBnk31xBnD93Ugvz41OKCxOTUvNSSeGc_Q0NLA0szC0djwioAflwvRw |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| Edition | 6 |
| ExternalDocumentID | CN1190968A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN1190968A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:14:05 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN1190968A3 |
| Notes | Application Number: CN19961095610 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980819&DB=EPODOC&CC=CN&NR=1190968A |
| ParticipantIDs | epo_espacenet_CN1190968A |
| PublicationCentury | 1900 |
| PublicationDate | 19980819 |
| PublicationDateYYYYMMDD | 1998-08-19 |
| PublicationDate_xml | – month: 08 year: 1998 text: 19980819 day: 19 |
| PublicationDecade | 1990 |
| PublicationYear | 1998 |
| RelatedCompanies | AMERICAN HOME PRODUCTS CORP |
| RelatedCompanies_xml | – name: AMERICAN HOME PRODUCTS CORP |
| Score | 2.47831 |
| Snippet | A compound of general formula (A) is described together with pharmaceutically acceptable acid addition salts thereof. The compound is a 5-HT1A antagonist which... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Piperazine derivatives and their use as 5-HT1A antagonists |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980819&DB=EPODOC&locale=&CC=CN&NR=1190968A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS8MwED_mFPVNpzK_8yB9K5q1XROhyJZuFMGuyJS9jWbN2F66sXb673vJVvVl5CUkcFzCXS53ufsF4IE7PGMTT9mMeTp0I1t2ylzHlmmKEtSiU7pJkI3b0Yf7OvJGNZhVtTAGJ_TbgCOiRk1Q30tzXi__glihya0sHuUchxYv_WEQWllVLqYtnBV2g14yCAfCEiIQsRW_BxQNH2-zzh7s60u0RtnvfXZ1Tcryv0Hpn8BBgrTy8hRqKm_Akaj-XWvA4dv2uRu7W80rzuA5mS_VymBBkwyl5ssAdhckzTNigv1kXSiSFsSzoyHt4Lh-btKwuMU53Pd7QxHZyMT4d71jEVfcOhdQzxe5agIxvgOTT8qVvitdLqk_cbD5NGXZlPJLaO6icrV76hqON0V26EryG6iXq7W6RStbyjuzQT8nhYEJ |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf9MHsbdGyjXUmi4EOMhUGMdPwtqxbibyMhQ39920LU19IX5o2uVybu17vevcrwJ1jOClJLK4TYsnQDevoMTENncWxkKAOnuNNgmzQ9d_Nl5k1q8FnVQujcEK_FTii0KhE6Hupzuv8L4jlqdzK4p4txNDyaRi6npZW5WLSwmle3x1MJ96EapS6NNCCNxcLw-d0SW8P9m2JzSsvTh99WZOS_zcow2M4mApaWXkCNZ41oUGrf9eacDjePneL7lbzilN4nC5yvlJY0CgVUvOlALsLFGcpUsF-tC44igtk6X6Ie2JcPjdJWNziDNrDQUh9XTAR_a43okHFrXEO9WyZ8RYg5TsQ9sBNZpvMdBi2E0M0G8cknWPnAlq7qFzunmpDww_Ho2j0HLxewdGm4E64lc411MvVmt8Ii1uyW7VZP1dng_Y |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Piperazine+derivatives+and+their+use+as+5-HT1A+antagonists&rft.inventor=A.+FENSOME&rft.inventor=M.+G.+KELLY&rft.inventor=H.+L.+MANSELL&rft.date=1998-08-19&rft.externalDBID=A&rft.externalDocID=CN1190968A |